|
Memórias do Instituto Oswaldo Cruz
Fundação Oswaldo Cruz, Fiocruz
ISSN: 1678-8060 EISSN: 1678-8060
Vol. 111, No. 8, 2016, pp. 512-516
|
Bioline Code: oc16076
Full paper language: English
Document type: Research Article
Document available free of charge
|
|
Memórias do Instituto Oswaldo Cruz, Vol. 111, No. 8, 2016, pp. 512-516
en |
Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre
da Silva, Rosiana Estéfane; Júnior, Antonio Toledo; Senna, Maria Camilo; Rabello, Ana & Cota, Gláucia
Abstract
Although intralesional meglumine antimoniate (MA) infiltration is considered an option for cutaneous leishmaniasis
(CL) therapy and is widely used in the Old World, there have been few studies supporting this therapeutic approach in
the Americas. This study aims to describe outcomes and adverse events associated with intralesional therapy for CL.
This retrospective study reviewed the experience of a Brazilian leishmaniasis reference centre using intralesional MA to
treat 31 patients over five years (2008 and 2013). The median age was 63 years (22-86) and the median duration time of
the lesions up to treatment was 16 weeks. In 22 patients (71%), intralesional therapy was indicated due to the presence of
contraindications or previous serious adverse events with systemic MA. Other indications were failure of systemic therapy
or ease of administration. Intralesional treatment consisted of one-six infiltrations (median three) for a period of up to 12
weeks. The initial (three months) and definitive (six months) cure rates were 70.9% and 67.7%, respectively. Most patients
reported mild discomfort during infiltration and no serious adverse events were observed. In conclusion, these results
show that the intralesional MA efficacy rate was very similar to that of systemic MA treatment, and reinforce the need for
further studies with adequate design to establish the efficacy and safety of this therapeutic approach.
Keywords
cutaneous leishmaniasis; therapy; intralesional infiltration; antimoniate meglumine
|
|
© Copyright 2016 - Memórias do Instituto Oswaldo Cruz Alternative site location: http://memorias.ioc.fiocruz.br
|
|